Literature DB >> 26965267

Evolution of Cell-Type-Specific RNA Aptamers Via Live Cell-Based SELEX.

Jiehua Zhou1, John J Rossi2,3.   

Abstract

Live cell-based SELEX (Systematic Evolution of Ligand EXponential enrichment) is a promising approach for identifying aptamers that can selectively bind to a cell-surface antigen or a particular target cell population. In particular, it offers a facile selection strategy for some special cell-surface proteins that are original glycosylated or heavily post-translationally modified, and are unavailable in their native/active conformation after in vitro expression and purification. In this chapter, we describe evolution of cell-type-specific RNA aptamers targeting the human CCR5 by combining the live cell-based SELEX strategy with high-throughput sequencing (HTS) and bioinformatics analysis.

Entities:  

Keywords:  Aptamer-mediated targeted siRNA delivery; Cell-type-specific RNA aptamer; High-throughput sequencing (HTS); Human CCR5 protein; Live cell-based SELEX

Mesh:

Substances:

Year:  2016        PMID: 26965267     DOI: 10.1007/978-1-4939-3591-8_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.

Authors:  Fengmei Pi; Hui Zhang; Hui Li; Varatharasa Thiviyanathan; David G Gorenstein; Anil K Sood; Peixuan Guo
Journal:  Nanomedicine       Date:  2016-11-25       Impact factor: 5.307

2.  Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3'-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery.

Authors:  Chandan Narayan; Suresh Veeramani; William H Thiel
Journal:  Nucleic Acid Ther       Date:  2021-11-10       Impact factor: 5.486

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.